Watch Ticker

CERo Therapeutics Holdings, Inc. Warrants

Go to CERo Therapeutics Holdings, Inc. Warrants Website

$0.02

0.00 (-0.51%)

Live

Previous Close

$0.0195

Day Range

$0.0175 - $0.0194

Previous Day Range

$0.0175 - $0.0199

Market Cap

$ USD

Day Vol.

2846

Previous Day Vol.

29784

Currency

USD

Primary Exchange

None

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integra...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

CERo Therapeutics Holdings, Inc. (CERO) has appointed Chris Ehrlich as its new CEO. The company is advancing the development of next-generation engineered T cell therapeutics for cancer treatment, with plans to initiate clinical trials for its lead product candidate CER-1236 in early 2025 for acute myeloid leukemia (AML).

Related tickers: CERO, CEROW.

Read Full Article

Trending Tickers

Please sign in to view